Horan Securities, Inc. Moderna, Inc. Transaction History

Horan Securities, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$135.66 - $197.02 $11,666 - $16,943	-86 Reduced 71.07%	35 $5,000
Q4 2022 Jan 17, 2023	SELL	$118.38 - $210.04 $355 - $630	-3 Reduced 2.42%	121 $0
Q2 2022 Jul 19, 2022	SELL	$117.13 - $176.59 $23,777 - $35,847	-203 Reduced 62.08%	124 $20,000
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $17,577 - $32,671	-139 Reduced 29.83%	327 $56,000
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $66,616 - $108,710	-295 Reduced 38.76%	466 $118,000
Q2 2021 Aug 05, 2021	SELL	$129.91 - $234.98 $56,510 - $102,216	-435 Reduced 36.37%	761 $179,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1,746 - $2,975	16 Added 1.36%	1,196 $157,000
Q4 2020 Feb 05, 2021	BUY	$65.74 - $169.86 $77,573 - $200,434	1,180 New	1,180 $123,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.